Last Updated: 03/02/2025

Formation and function of the parasitophorous vacuole membrane in Plasmodium falciparum-infected erythrocytes

Objectives

The study aims to understand the formation of of the membrane of the parasitophorous vacuole (PVM) and the essential functions of the proteins present in this membrane during the growth of the malaria parasite Plasmodium falciparum in erythrocytes.
 

Principal Investigators / Focal Persons

Christiaan van Ooij

Rationale and Abstract

During entry into the erythrocyte, the parasite becomes surrounded by a membrane that forms the PV, the PV membrane (PVM), that envelops the parasite until the very last stages of the erythrocytic cycle. As the parasite grows, the PVM expands to accommodate the growing parasite. The PVM separates the parasite from the cytosol of the erythrocyte, but also forms a significant barrier to the export of parasite proteins to the host cell that are required for the survival of the parasite and the uptake of haemoglobin and nutrients from the erythrocyte.

The proposed research addresses the following questions:

  1. what is the origin of the phospholipids that make up the PVM when it is made and when it expands and how does the parasite phospholipid transfer protein PFA0210c affect this process; and
  2. what are the functions of the proteins in the PVM; and how does the PVM allow survival of the parasite inside the erythrocyte.

These questions will be addressed using a combination of genetic techniques newly adapted for use in Plasmodium parasites (Cas9-mediated gene modification and inducible gene removal using the rapamycin-inducible diCre system), biochemical approaches, and automated EM microscopy that allows 3D models of parasites to be produced.  Together, the proposed experiments will provide insight into the function of the PVM and will reveal the essential functions of PVM proteins. Furthermore, this research could reveal entirely new targets for use in anti-malarial drug development.

Date

Feb 2018 — Jan 2023

Total Project Funding

$1.56M

Funding Details
Medical Research Council (MRC), United Kingdom

Grant ID: MR/R008485/1
GBP 1.1M
Project Site

United Kingdom

SHARE
SHARE